The initial CT blend sign is not associated with poor patient outcomes after stereotactic minimally invasive surgery.
Aged
Cerebral Hemorrhage
/ complications
Female
Hematoma
/ diagnostic imaging
Humans
Image Interpretation, Computer-Assisted
/ methods
Imaging, Three-Dimensional
/ methods
Male
Middle Aged
Minimally Invasive Surgical Procedures
/ methods
Neuroimaging
/ methods
Retrospective Studies
Stereotaxic Techniques
Tomography, X-Ray Computed
/ methods
Treatment Outcome
Glasgow coma scale
Intracerebral haemorrhage
National Institute of health stroke scale. Blend signs
Stereotactic minimally invasive surgery
Journal
BMC neurology
ISSN: 1471-2377
Titre abrégé: BMC Neurol
Pays: England
ID NLM: 100968555
Informations de publication
Date de publication:
15 Apr 2021
15 Apr 2021
Historique:
received:
26
06
2020
accepted:
02
04
2021
entrez:
16
4
2021
pubmed:
17
4
2021
medline:
16
6
2021
Statut:
epublish
Résumé
The initial CT blend sign is an imaging marker that has been used to predict haematoma expansion and poor outcomes in patients with small-volume intracerebral haemorrhage (ICH). However, the association of the blend sign with the outcomes of patients undergoing surgery remains unclear. The present study aimed to retrospectively evaluate the influence of the initial CT blend sign on short-term outcomes in patients with hypertensive ICH after stereotactic minimally invasive surgery (sMIS). We enrolled 242 patients with spontaneous ICH. The patients were assigned to the blend sign group (91 patients) or non-blend sign (control) group (151 patients) based on the initial CT features. The NIHSS, GCS and mRS were used to assess the effects of sMIS. The rates of severe pulmonary infection and cardiac complications were also compared between the two groups. Statistically significant differences in the NIHSS and GCS scores were not observed between the blend sign group and the control group. No significant differences in the proportion of patients with good outcomes during the follow-up period were observed between the two groups. A higher rate of re-haemorrhage was noted in the blend sign group. Significant differences in the rates of severe pulmonary infection and cardiac complications were not observed between the two groups. The initial CT blend sign is not associated with poor outcomes in patients with hypertensive ICH after sMIS. ICH patients with the CT blend sign should undergo sMIS if they are suitable candidates for surgery.
Sections du résumé
BACKGROUND
BACKGROUND
The initial CT blend sign is an imaging marker that has been used to predict haematoma expansion and poor outcomes in patients with small-volume intracerebral haemorrhage (ICH). However, the association of the blend sign with the outcomes of patients undergoing surgery remains unclear. The present study aimed to retrospectively evaluate the influence of the initial CT blend sign on short-term outcomes in patients with hypertensive ICH after stereotactic minimally invasive surgery (sMIS).
METHODS
METHODS
We enrolled 242 patients with spontaneous ICH. The patients were assigned to the blend sign group (91 patients) or non-blend sign (control) group (151 patients) based on the initial CT features. The NIHSS, GCS and mRS were used to assess the effects of sMIS. The rates of severe pulmonary infection and cardiac complications were also compared between the two groups.
RESULTS
RESULTS
Statistically significant differences in the NIHSS and GCS scores were not observed between the blend sign group and the control group. No significant differences in the proportion of patients with good outcomes during the follow-up period were observed between the two groups. A higher rate of re-haemorrhage was noted in the blend sign group. Significant differences in the rates of severe pulmonary infection and cardiac complications were not observed between the two groups.
CONCLUSIONS
CONCLUSIONS
The initial CT blend sign is not associated with poor outcomes in patients with hypertensive ICH after sMIS. ICH patients with the CT blend sign should undergo sMIS if they are suitable candidates for surgery.
Identifiants
pubmed: 33858371
doi: 10.1186/s12883-021-02181-0
pii: 10.1186/s12883-021-02181-0
pmc: PMC8048306
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
160Subventions
Organisme : Natural Science Foundation of China
ID : 81971126/H0906
Organisme : Medical Speciality and Community Project Construction in Baoshan District -Neurorehabilitation Speciality
ID : BSZK-2018-A01
Organisme : the High-level Overseas Talents Innovation and Entrepreneurship Merit-based Funding Projects
ID : (2020) 05
Références
J Korean Neurosurg Soc. 2015 Oct;58(4):309-15
pubmed: 26587182
Lancet Neurol. 2016 Nov;15(12):1228-1237
pubmed: 27751554
PLoS One. 2017 Aug 22;12(8):e0183082
pubmed: 28829797
Stroke. 2015 Jul;46(7):2032-60
pubmed: 26022637
Oncotarget. 2017 Jul 18;8(51):89348-89363
pubmed: 29179524
Int J Stroke. 2014 Aug;9(6):741-6
pubmed: 24025067
World Neurosurg. 2018 Dec;120:e1000-e1010
pubmed: 30201578
Lancet. 2005 Jan 29-Feb 4;365(9457):387-97
pubmed: 15680453
Stroke. 1997 Jan;28(1):1-5
pubmed: 8996478
Neuropharmacology. 2018 May 15;134(Pt B):240-248
pubmed: 28947377
World Neurosurg. 2018 Dec;120:e153-e160
pubmed: 30092481
Neurocrit Care. 2021 Feb;34(1):259-270
pubmed: 32462410
J Clin Neurosci. 2014 Feb;21(2):221-4
pubmed: 24035424
BMC Neurol. 2017 Jul 6;17(1):131
pubmed: 28683728
Acta Neurochir Suppl. 2011;111:381-2
pubmed: 21725786
PLoS One. 2018 Jun 26;13(6):e0199809
pubmed: 29944717
J Stroke. 2017 Jan;19(1):28-39
pubmed: 28178413
Neurosurgery. 2017 Apr 1;80(4):515-524
pubmed: 27322807
Stroke. 2015 Aug;46(8):2119-23
pubmed: 26089330
World Neurosurg. 2016 Apr;88:306-310
pubmed: 26739904
Clin Neurol Neurosurg. 2017 Dec;163:84-89
pubmed: 29078128
Front Neurol Neurosci. 2015;37:107-29
pubmed: 26588167
Lancet. 2019 Mar 9;393(10175):1021-1032
pubmed: 30739747